Boston Scientific Files 2024 10-K

Ticker: BSX · Form: 10-K · Filed: 2025-02-18T00:00:00.000Z

Sentiment: neutral

Topics: 10-K, annual-report, financials

TL;DR

BSX dropped its 2024 10-K. Full financials and risks detailed.

AI Summary

Boston Scientific Corporation filed its 2024 10-K on February 18, 2025, detailing its financial performance for the fiscal year ending December 31, 2024. The filing provides comprehensive information on the company's operations, financial condition, and risk factors. Key financial data and operational highlights for 2024 are presented, alongside comparative figures from previous years.

Why It Matters

This filing provides investors and analysts with a detailed look into Boston Scientific's financial health and strategic direction for the past year, crucial for understanding its market position and future prospects.

Risk Assessment

Risk Level: medium — The filing contains standard risk factors inherent to a large medical device company, including market competition, regulatory changes, and product development challenges.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this 10-K filing?

The primary purpose of this 10-K filing is to provide a comprehensive annual report of Boston Scientific Corporation's financial performance, business operations, and risk factors for the fiscal year ending December 31, 2024.

When was this 10-K filed with the SEC?

This 10-K filing was filed with the SEC on February 18, 2025.

What is Boston Scientific Corporation's fiscal year end?

Boston Scientific Corporation's fiscal year ends on December 31st.

What is the company's primary business address?

The company's primary business address is 300 Boston Scientific Way, Marlborough, MA 01752-1234.

What standard industrial classification code is associated with Boston Scientific Corp?

Boston Scientific Corp is associated with the standard industrial classification code 3841, which is for Surgical & Medical Instruments & Apparatus.

From the Filing

0000885725-25-000011.txt : 20250218 0000885725-25-000011.hdr.sgml : 20250218 20250218161339 ACCESSION NUMBER: 0000885725-25-000011 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 102 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250218 DATE AS OF CHANGE: 20250218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 25635023 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 10-K 1 bsx-20241231.htm 10-K bsx-20241231 0000885725 2024 FY false P3Y P7Y P2Y P5Y P1Y P1Y http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#AccountsPayableCurrent http://fasb.org/us-gaap/2024#AccountsPayableCurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent P3Y P4Y P10Y P5Y 467 203 190 181 273 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure iso4217:HKD xbrli:shares iso4217:EUR utr:Rate bsx:installment bsx:segment 0000885725 2024-01-01 2024-12-31 0000885725 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0000885725 bsx:SeniorNotedue2027Member 2024-01-01 2024-12-31 0000885725 2024-06-30 0000885725 2025-01-31 0000885725 2023-01-01 2023-12-31 0000885725 2022-01-01 2022-12-31 0000885725 2024-12-31 0000885725 2023-12-31 0000885725 us-gaap:PreferredStockMember 2023-12-31 0000885725 us-gaap:PreferredStockMember 2022-12-31 0000885725 us-gaap:PreferredStockMember 2021-12-31 0000885725 us-gaap:PreferredStockMember 2024-01-01 2024-12-31 0000885725 us-gaap:PreferredStockMember 2023-01-01 2023-12-31 0000885725 us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0000885725 us-gaap:PreferredStockMember 2024-12-31 0000885725 us-gaap:CommonStockMember 2023-12-31 0000885725 us-gaap:CommonStockMember 2022-12-31 0000885725 us-gaap:CommonStockMember 2021-12-31 0000885725 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0000885725 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0000885725 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000885725 2022-12-31 0000885725 us-gaap:CommonStockMember 2024-12-31 0000885725 us-gaap:TreasuryStockCommonMember 2023-12-31 0000885725 us-gaap:TreasuryStockCommonMember 2022-12-31 0000885725 us-gaap:TreasuryStockCommonMember 2021-12-31 0000885725 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-12-31 0000885725 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-12-31 0000885725 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-12-31 0000885725 us-gaap:TreasuryStockCommonMember 2024-12-31 0000885725 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000885725 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000885725 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000885725 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0000885725 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0000885725 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0000885725 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000885725 us-gaap:RetainedEarningsMember 2023-12-31 0000885725 us-gaap:RetainedEarningsMember 2022-12-31 0000885725 us-gaap:RetainedEarningsMember 2021-12-31 0000885725 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0000885725 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0000885725 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000885725 us-gaap:Retain

View on Read The Filing